Observational studyFrontiers in immunology2026
Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study.
Pan Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.